Press release
Asthma Competitive Landscape Report (Updated) | Areteia Therapeutics, Celltrion, GlaxoSmithKline, Connect Biopharma, Shanghai Hengrui Pharmaceutical Co., Ltd., and others.
Asthma Market
Key Takeaways from the Asthma Competitive Landscape Report
• DelveInsight's Asthma report depicts a robust space with 110+ Asthma companies working to develop 125+ pipeline therapies for Asthma treatment.
• The leading Asthma Companies working in the market include Areteia Therapeutics, Celltrion, GlaxoSmithKline, Connect Biopharma, Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Chia Tai Tianqing Pharmaceutical Group, Aldeyra Therapeutics, Inc., Trio Medicines, AstraZeneca, Janssen Research & Development, Palobiofarma SL, Sanofi, RAPT Therapeutics, Kashiv BioSciences, Archivel Farma, TFF Pharmaceuticals, Evelo Biosciences Inc., Landos Biopharma, Adial Pharmaceuticals, Holth Therapeutics, Lanier Biotherapeutics, Omega Therapeutics, Transpire Bio, DNARx, Argenx, MyMD Pharmaceuticals, Ventyx Biosciences, Kither, Enterprise Therapeutics, and others.
• Promising Asthma therapies in the various stages of development include DUPIXENT®, Tezepelumab, MEDI9929, Revamilast, Benralizumab, AZD7594, GSK3511294 (Depemokimab), ONO-6950, Montelukast, and others.
• December 2023: Sanofi announced a study of Phase 4 clinical trials for Dupilumab. A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma.
• December 2023: AstraZeneca announced a study of phase 4 clinical trials for Tezepelumab. To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied populations in the United States.
Request a sample and discover the recent advances in Asthma Drugs @ Asthma Competitive Landscape Report- https://www.delveinsight.com/report-store/asthma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Asthma report provides in-depth commercial assessment of drugs that have been included, which comprises collaboration, agreement, licensing and acquisition - deals values trends. The sub-segmentation is described in the Asthma report which provide company-company collaboration (licensing/partnering), company academic collaboration and acquisition analysis in tabulated form.
Asthma Overview
Asthma is a chronic disease that affects the airways. Asthma is characterized by inflammation and spasm of the airways. The airways are tubes that carry air in and out of the lungs. If a person has asthma, the inside walls of the airways become sore and swollen. The air passages in the lungs become narrow due to inflammation and tightening of the muscles around the small airways.
Find out more about Asthma Analytical Perspective: In-depth Commercial Assessment @ Asthma Collaboration Analysis by Companies- https://www.delveinsight.com/sample-request/asthma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Asthma Companies and Therapies
• Regeneron Pharmaceuticals: Dupixent
• Novartis Pharmaceuticals: QVM149
• Areteia Therapeutics: Dexpramipexole
• Connect Biopharma: CBP-201
• United BioPharma: UB-221
• 4D Pharma Plc.: MRx-4DP0004
Asthma Competitive Landscape: Analytical Perspectives
The Asthma competitive landscape report comprises of comparative assessment of Companies (by therapy, development stage, and technology).
Asthma Report Assessment
• Company Analysis
• Asthma Therapeutic Assessment
• Asthma Pipeline Assessment
• Inactive Asthma drugs assessment
• Asthma Unmet Needs
Learn more about the emerging Asthma Competitive Landscape @ Asthma Market Drivers and Barriers, Unmet Needs- https://www.delveinsight.com/sample-request/asthma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Asthma Competitive Landscape Report
• Coverage- Global
• Asthma Companies- Areteia Therapeutics, Celltrion, GlaxoSmithKline, Connect Biopharma, Shanghai Hengrui Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Chia Tai Tianqing Pharmaceutical Group, Aldeyra Therapeutics, Inc., Trio Medicines, AstraZeneca, Janssen Research & Development, Palobiofarma SL, Sanofi, RAPT Therapeutics, Kashiv BioSciences, Archivel Farma, TFF Pharmaceuticals, Evelo Biosciences Inc., Landos Biopharma, Adial Pharmaceuticals, Holth Therapeutics, Lanier Biotherapeutics, Omega Therapeutics, Transpire Bio, DNARx, Argenx, MyMD Pharmaceuticals, Ventyx Biosciences, Kither, Enterprise Therapeutics, and others.
• Asthma therapies- DUPIXENT®, Tezepelumab, MEDI9929, Revamilast, Benralizumab, AZD7594, GSK3511294 (Depemokimab), ONO-6950, Montelukast, and others.
• Asthma Therapeutics Assessment- Product Type, Stage and Product Type, Route of Administration, Stage and Route of Administration, Molecule Type, Stage and Molecule Type
Dive deep into rich insights for new drugs for Asthma Product Developmental Activities, Visit @ Asthma Research and Development Activities- https://www.delveinsight.com/sample-request/asthma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Asthma: Overview
4. Asthma-Analytical Perspective: In-depth Commercial Assessment
5. Asthma Competitive Landscape
6. Asthma Therapeutic Assessment
7. Asthma: Company and Product Profiles (Marketed Therapies)
8. Regeneron Pharmaceuticals
9. Dupixent
10. Asthma: Company and Product Profiles (Pipeline Therapies)
11. Late Stage Products (Phase III)
12. Areteia Therapeutics
13. Dexpramipexole
14. Drug profiles in the detailed report…..
15. Mid Stage Products (Phase II)
16. Connect Biopharma
17. CBP-201
18. Drug profiles in the detailed report…..
19. Early Stage Products (Phase I)
20. United BioPharma
21. UB-221
22. Drug profiles in the detailed report…..
23. Preclinical and Discovery Stage Products
24. Olatec Therapeutics
25. Dapansutrile
26. Drug profiles in the detailed report…..
27. Inactive Products
28. Asthma Unmet needs
29. Asthma Market drivers and barriers
30. Appendix
For further information on the Asthma Report @ Asthma Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/asthma-competitive-landscape?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Top Selling Market Research Reports in 2024
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Chronic Neuropathic Pain Market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Hydrocephalus Treatment Market- https://www.delveinsight.com/report-store/hydrocephalus-market
Cancer Therapy Market- https://www.delveinsight.com/report-store/cancer-therapy-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Methicillin-resistant Staphylococcus Aureus Mrsa Infection Market- https://www.delveinsight.com/report-store/methicillin-resistant-staphylococcus-aureus-mrsa-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Polycystic Ovarian Syndrome Market- https://www.delveinsight.com/report-store/polycystic-ovarian-syndrome-market
Radiodermatitis Market- https://www.delveinsight.com/report-store/radiodermatitis-market
Rhinosinusitis Market- https://www.delveinsight.com/report-store/rhinosinusitis-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Wilms Tumor Market- https://www.delveinsight.com/report-store/wilms-tumor-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Venous Thromboembolism Market- https://www.delveinsight.com/report-store/venous-thromboembolism-market
Beta Thalassemia Market- https://www.delveinsight.com/report-store/beta-thalassemia-market
Cold Agglutinin Disease Market- https://www.delveinsight.com/report-store/cold-agglutinin-disease-cad-market
Postpartum Depression Market- https://www.delveinsight.com/report-store/postpartum-depression-ppd-market
Radiation Dermatitis Market- https://www.delveinsight.com/report-store/radiation-dermatitis-market
Synovial Sarcoma Market- https://www.delveinsight.com/report-store/synovial-sarcoma-market
Tendinopathy Market- https://www.delveinsight.com/report-store/tendinopathy-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Diabetic Nephropathy Market- https://www.delveinsight.com/report-store/diabetic-nephropathy-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Pcsk9 Inhibitors Market- https://www.delveinsight.com/report-store/pcsk9-inhibitors-market
Respiratory Syncytial Virus Market- https://www.delveinsight.com/report-store/respiratory-syncytial-virus-rsv-market
Chemotherapy Induced Neutropenia Market- https://www.delveinsight.com/report-store/chemotherapy-induced-neutropenia-cin-market
Glioblastoma Multiforme Market- https://www.delveinsight.com/report-store/glioblastoma-multiforme-gbm-market
Immune Thrombocytopenia Market- https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Cystic Fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Primary Biliary Cholangitis Market- https://www.delveinsight.com/report-store/primary-biliary-cholongitis-pbc-market
Progressive Supranuclear Palsy Market- https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market
Membranous Nephropathy Market- https://www.delveinsight.com/report-store/membranous-nephropathy-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Diabetic Retinopathy Market- https://www.delveinsight.com/report-store/diabetic-retinopathy-market
Post Operative Pain Market- https://www.delveinsight.com/report-store/postoperative-pain-market
Genital Herpes Market- https://www.delveinsight.com/report-store/genital-herpes-market
Axillary Hyperhidrosis Market- https://www.delveinsight.com/report-store/axillary-hyperhidrosis-ahh-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Yash Bhardwaj
info@delveinsight.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma Competitive Landscape Report (Updated) | Areteia Therapeutics, Celltrion, GlaxoSmithKline, Connect Biopharma, Shanghai Hengrui Pharmaceutical Co., Ltd., and others. here
News-ID: 3573279 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Asthma
Evolving Market Trends In The Asthma Spacers Industry: Smart Inhaler Devices Rev …
The Asthma Spacers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Asthma Spacers Market Size During the Forecast Period?
The asthma spacers market has grown steadily, forecasted to rise from $1.88 billion in 2024 to $2.01 billion in 2025 at a CAGR…
Asthma Relief Reimagined: Trends Driving Asthma Spacer Innovation
The Business Research Company recently released a comprehensive report on the Global Asthma Spacers Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Asthma Warning Sensors Market Connected Care for Asthma: How Warning Sensors Imp …
Asthma Warning Sensors Market Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Asthma Warning Sensors Market Size, Share & Trends Analysis Report By Type (Wearable v/s Non-Wearable), By Technology (AI, IoT, Machine Learning, Others), By Parameter Measured (FEV1 v/s Peak Flow), By End User (Hospitals & Clinics v/s Homecare)- Market…
Asthma Spacers Market Optimizing Asthma Treatment: How Spacers are Improving Del …
Asthma Spacers Market Assessment worth $ 2.47 Billion by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Asthma Spacers Market- by Product (Space Chamber Plus, A2A Spacer, Flo-Tone CR, Able Spacer, AeroChamber, Volumatic, Vortex, OptiChamber), Application (Hospital Pharmacies, Online Pharmacies and Retail Pharmacies), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get a free sample copy of…
Severe Asthma Treatment Market - Revitalizing Quality of Life: Severe Asthma Tre …
Newark, New Castle, USA: The "Severe Asthma Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Severe Asthma Treatment Market: https://www.growthplusreports.com/report/severe-asthma-treatment-market/8939
This latest report researches the industry structure,…
Asthma Monitoring Devices Market - Revolutionizing Asthma Care: Elevate Monitori …
Newark, New Castle, USA: The "Asthma Monitoring Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Asthma Monitoring Devices Market: https://www.growthplusreports.com/report/asthma-monitoring-devices-market/8697
This latest report researches the industry structure,…
